Vinblastine
- Molecular formula
- C46H58N4O9
- CAS Number
- 865-21-4
- IUPAC Name
- benzyl N-[[(6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate
- Molecular Weight
- 811.95g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3001g/cm3
- Synonyms
- metergoline
Identification
Exploring Benzyl N-[[(6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate
Benzyl N-[[(6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate is a fascinating compound that falls within the realm of complex organic chemistry. This molecule is noteworthy for its dual functionality involving an indoloquinoline core, which is often associated with a variety of biological activities.
Key Characteristics
- Structural Complexity: This compound features a unique indoloquinoline structure, which consists of a fused indole and quinoline system. Such structures can exhibit significant pharmacological properties, making them of interest in medicinal chemistry.
- Potential Biological Activity: Compounds like this one have been studied for their roles in various biological processes, including their potential anticancer and antimicrobial properties. The presence of the carbamate moiety further enhances the biological relevance.
- Applications in Drug Design: Chemists are particularly excited about compounds with such diverse scaffolds, as they can lead to the development of new drugs targeting specific diseases. The indoloquinoline framework is known for its ability to modulate biological pathways efficiently.
Research Insights
Recent studies have shown that indoloquinoline derivatives can:
- Inhibit specific enzyme activities that are critical in disease progression.
- Interact with neurotransmitter receptors, which may have implications for treating neurodegenerative diseases.
- Exhibit anti-inflammatory properties, making them potential candidates for treating chronic inflammatory conditions.
The exploration of benzyl N-[[[6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate thus opens avenues for breakthroughs in drug development. As we delve into its properties, we unveil a world of possibilities that this compound may hold for future therapeutic applications.